To BE or to PE: Prime editors provide more choices for epitope-editing-based immunotherapy. Yin SM, Li DL. Cell Stem Cell 2024;31:1557-1559.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yin SM, Li DL. To BE or to PE: Prime editors provide more choices for epitope-editing-based immunotherapy. Cell Stem Cell 2024;31:1557-1559.
PMID: 39515298